The field of geroscience and longevity has been evolving to find new ways to define aging for drug discovery. In this issue’s cover story, we explore how clinical researchers are quantifying aging in drug development and testing new ways to receive regulatory recognition.
Also in this issue, we take a look at sustainability trends in cleanroom technology, and outsourced drug manufacturing. An exclusive interview also elucidates how to navigate ethical questions that come up while studying and developing therapies to treat rare disorders.
Don’t miss the latest on digital therapeutics being approved in the field of neurological disorders, and how companies are tackling regulatory requirements in that space.
This issue also included a thematic supplement focused on the role and impact of cloud technologies in pharma.
Read the latest issue of Pharma Technology Focus for all this and insights, and analysis from the pharmaceutical industry.
You can also subscribe here to receive email notifications when a new issue is available.
